"Unveiling the Controversial World of Weight Loss Drug Discounts: Price, PBMs, and Coverage Under Scrutiny"

A new study reveals that popular weight loss drugs are being discounted by more than half from their list prices, raising concerns about patients' access to the products and out-of-pocket spending. The gap between list prices and actual payments is common, but the GLP-1 drugs stand out as one of the fastest-selling categories, with many individuals paying significantly higher list prices out-of-pocket.